Platelet response to aspirin in UK and Irish pregnancy cohorts: a genome-wide approach

References

• Brown MA, Lindheimer MD, de Swiet V, van Assche A, Mountquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:9–143. doi:10.1081/PRG-100104165.
   Web of Science ®Google Scholar
• Atallah A, Lecarpentier E, Goffinet F, Doret-Dion M, Gaucherand P, Tsatsaris V . Aspirin for prevention of preeclampsia. Drugs 2017;77(17):1819–1831. doi:10.1007/s40265-017-0823-0.
   PubMed Web of Science ®Google Scholar
• Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 2017;377(7):613–622. doi:10.1056/NEJMoa1704559.
   PubMed Web of Science ®Google Scholar
• Fitzgerald R, Pirohamed M. Aspirin resistance: effect of clinical, biochemical and genetic factors. Pharmacol Ther 2011;130(2):213–225. doi:10.1016/j.pharmthera.2011.01.011.
   PubMed Web of Science ®Google Scholar
• Bhala N, Emberson J, Merhi A, Abramson S, Arber, N, Baron, JA, Bombardier, C, Cannon, C, Farkouh, ME, FitzGerald, GA, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 2013;382:769–779.
   PubMed Web of Science ®Google Scholar
• Navaratnam K, Alfirevic A, Alfirevic Z. Low dose aspirin and pregnancy: how important is aspirin resistance?. BJOG 2016;123(9):1481–1487. doi:10.1111/1471-0528.13914.
   PubMed Web of Science ®Google Scholar
• Patrono C, Coller B, Dalen JE, Fuster V, Gent M, Harker LA, Hirsh J, Roth G . Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest 1998;114:470s–488s. doi:10.1378/chest.114.5_Supplement.470S.
   PubMed Web of Science ®Google Scholar
• Hutt R, Ogunniyi SO, Sullivan MH, Elder MG. Increased platelet volume and aggregation precede the onset of preeclampsia. Obstet Gynecol 1994;83:146–149.
   PubMed Web of Science ®Google Scholar
• Walsh SW. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1985;152(3):335–340. doi:10.1016/S0002-9378(85)80223-4.
   PubMed Web of Science ®Google Scholar
• Schiff E, Peleg E, Goldenberg M, Rosenthal T, Ruppin E, Tamarkin M, Barkai G, Ben-Baruch G, Yahal I, Blankstein J, et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Eng J Med 1989;321(6):351–356. doi:10.1056/NEJM198908103210603.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Mirro R, Chesney CM, Leffler C. Low-dose aspirin in pregnancy. Obstet Gynecol 1989;74:551–557.
   PubMed Web of Science ®Google Scholar
• Spitz B, Magness RR, Cox SM, Brown CEL, Rosenfeld CR, Gant NF . Low-dose aspirin. I. Effect on angiotensin II pressor responses and blood prostaglandin concentrations in pregnant women sensitive to angiotensin II. Am J Obstet Gynecol 1988;159(5):1035–1043. doi:10.1016/0002-9378(88)90406-1.
   PubMed Web of Science ®Google Scholar
• Thorp JA, Walsh SW, Brath PC. Low-dose aspirin inhibits thromboxane, but not prostacyclin, production by human placental arteries. Am J Obstet Gynecol 1988;159:1381–1384. doi:10.1016/0002-9378(88)90560-1.
   PubMed Web of Science ®Google Scholar
• Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest J-C, Giguère Y . Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010;116(2):402–414. doi:10.1097/AOG.0b013e3181e9322a.
   PubMed Web of Science ®Google Scholar
• Lindsay D, Levine LD, Holland TL, Kim K, Mumford SL, Schisterman EF . The role of aspirin and inflammation on reproduction: the EAGeR trial. Can J Physiol Pharmacol 2019;97(3):187–192. doi:10.1139/cjpp-2018-0368.
   PubMed Web of Science ®Google Scholar
• Giannakou K, Evangelou E, Papathedorou SI. Genetic and non-genetic risk factors for preeclampsia: umbrella review of systematic reviews and meta-analyses of observational studies. Ultrasound Obstet Gynecol 2018;51:720–730. doi:10.1002/uog.18959.
   PubMed Web of Science ®Google Scholar
• Eudy AM, Voora D, Myers RA, Clowse MEB. Effect of aspirin response signature gene expression on preterm birth and preeclampsia among women with lupus: a pilot study. Lupus 2019;28(14):1640–1647. doi:10.1177/0961203319886069.
   PubMed Web of Science ®Google Scholar
• Mone F, Mulcahy C, McParland P, Breathnach F, Downey P, McCormack D, Culliton M, Stanton A, Cody F, Morrison JJ, et al. Trial of feasibility and acceptability of routine low-dose aspirin versus Early Screening Test indicated aspirin for preeclampsia prevention (TEST study): a multicentre randomised controlled trial. BMJ Open 2018;8:e022056. doi:10.1136/bmjopen-2018-022056.
   PubMed Web of Science ®Google Scholar
• Fox SC, May JA, Shah A, Neubert U, Heptinstall S. Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin. Platelets 2009;20:250–259. doi:10.1080/09537100902912451.
   PubMed Web of Science ®Google Scholar
• Dovlatova N, May JA, Fox SC. Remote platelet function testing–Significant progress towards widespread testing in clinical practice. Platelets 2015;26:399–401. doi:10.3109/09537104.2015.1043880.
   PubMed Web of Science ®Google Scholar
• Navaratnam K, Alfirevic A, Jorgensen A, Alfirevic Z. Aspirin non-responsiveness in pregnant women at high-risk of preeclampsia. Eur J Obstet Gynecol Reprod Biol 2018;221:144–150. doi:10.1016/j.ejogrb.2017.12.052.
   PubMed Web of Science ®Google Scholar
• Grove EL, Hvas A-M, Johnsen HL, Hedegaard SS, Pedersen SB, Mortensen J, Kristensen SD . A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease. Thromb Haemost 2010;103(6):1245–1253. doi:10.1160/TH09-08-0527.
   PubMed Web of Science ®Google Scholar
• Cattaneo M. Laboratory detection of ‘aspirin resistance’: what test should we use (if any)?. Eur Heart J 2007;28:1673–1675. doi:10.1093/eurheartj/ehm232.
   PubMed Web of Science ®Google Scholar
• Pandey CP, Misra A, Negi MS, Kanuri BN, Chhonker YS, Bhatta R, Narain V, Dikshit M . Aspirin & clopidogrel non-responsiveness & its association with genetic polymorphisms in patients with myocardial infarction. Indian J Med Res 2019;150(1):50–61. doi:10.4103/ijmr.IJMR_782_17.
   PubMed Web of Science ®Google Scholar
• Lewis JP, Riaz M, Xie S, Polekhina G, Wolfe R, Nelson M, Tonkin AM, Reid CM, Murray AM, McNeil JJ, et al. Genetic variation in PEAR1, cardiovascular outcomes and effects of aspirin in a healthy elderly population. Clin Pharmacol Ther 2020;108:1289–1298. doi:10.1002/cpt.1959.
   PubMed Web of Science ®Google Scholar
• Ferreira M, Freitas-Silva M, Assis J, Pinto R, Nunes JP, Medeiros R . The emergent phenomenon of aspirin resistance: insights from genetic association studies. Pharmacogenomics 2020;21:125–140. doi:10.2217/pgs-2019-0133.
   PubMed Web of Science ®Google Scholar
• Liu WW, Wang H, Chen XH, Fu SW, Liu ML. miR-34b-3p may promote antiplatelet efficiency of aspirin by inhibiting thromboxane synthase expression. Thromb Haemost 2019;119:1451–1460. doi:10.1055/s-0039-1692681.
   PubMed Web of Science ®Google Scholar
• Massimi I, Alemanno L, Guarino ML, Guerriero R, Mancone M, Ceccacci A, Frati L, Angiolillo D, Pulcinelli F . aspirin-dependent effects on purinergic P2Y1 receptor expression. Thromb Haemost 2019;119(5):726–734. doi:10.1055/s-0039-1678707.
   PubMed Web of Science ®Google Scholar
• Lewis JP. Implementation of genotype-guided antiplatelet therapy: feasible but not without obstacles. Circ Genom Precis Med 2018;11:e002118. doi:10.1161/CIRCGEN.118.002118.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yan X, Feng X, Bu J, Dong Y, Lin P, Hayashi Y, Huang R, Olsson A, Andreassen PR, et al. Setd2 regulates quiescence and differentiation of adult hematopoietic stem cells by restricting RNA polymerase II elongation. Haematologica 2018;103(7):1110–1123. doi:10.3324/haematol.2018.187708.
   PubMed Web of Science ®Google Scholar
• Gao Z, Chen X, Zhu K, Zeng P, Ding G. Dab1 contributes to angiotensin II-induced apoptosis via p38 signaling pathway in podocytes. Biomed Res Int 2017;2484303. doi:10.1155/2017/2484303.
   Google Scholar
• Navaratnam K, Alfirevic Z, Pirmohamed M, Alfirevic A. How important is aspirin adherence when evaluating effectiveness of low-dose aspirin?. Eur J Obstet Gynecol Reprod Biol 2017;219:1–9. doi:10.1016/j.ejogrb.2017.10.004.
   PubMed Web of Science ®Google Scholar
• Shanmugalingam R, Wang X, Munch G, Fulcher I, Lee G, Chau K, Xu B, Kumar R, Hennessy A, Makris A, et al. A pharmacokinetic assessment of optimal dosing, preparation, and chronotherapy of aspirin in pregnancy. Am J Obstet Gynecol 2019;221:255.e1–255.e9. doi:10.1016/j.ajog.2019.04.027.
   PubMed Web of Science ®Google Scholar
• Mone F, Mulcahy C, McParland P, McAuliffe FM. Should we recommend universal aspirin for all pregnant women?. Am J Obstet Gynecol 2017;216:141.e1–141.e5. doi:10.1016/j.ajog.2016.09.086.
   PubMed Web of Science ®Google Scholar
• Hastie R, Tong S, Wikstrom A-K, Sandstrom A, Hesselman S, Bergman L. Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study. Am J Obstet Gynecol 2021;224(1):95.e1–95.e12. doi:10.1016/j.ajog.2020.07.023.
   PubMed Web of Science ®Google Scholar